These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5785442)

  • 41. Gonadal and erectile dysfunction in diabetics.
    Hijazi RA; Betancourt-Albrecht M; Cunningham GR
    Med Clin North Am; 2004 Jul; 88(4):933-45, xi. PubMed ID: 15308386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients.
    Ferreira U; Leitao VA; Denardi F; Matheus WE; Stopiglia RM; Netto NR
    Prostate Cancer Prostatic Dis; 2006; 9(1):39-41. PubMed ID: 16276352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms of disease: pharmacogenetics of testosterone therapy in hypogonadal men.
    Zitzmann M
    Nat Clin Pract Urol; 2007 Mar; 4(3):161-6. PubMed ID: 17347661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hormonal control of sexual behavior in males and endocrinologic causes of sexual dysfunction].
    Manieri C; Di Bisceglie C; Tagliabue M; Fornengo R; Zumpano E
    Minerva Endocrinol; 1997 Jun; 22(2):37-43. PubMed ID: 9304046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Andropause, male climacteric and crisis of the fifties: should androgens be administered?].
    Martin-Du Pan R; Martin-du Pan S; Sindelar P
    Rev Med Suisse Romande; 1995 Mar; 115(3):257-62. PubMed ID: 7777768
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of sex offenders with leuprorelin].
    Nøttestad JA; Bjarnar E; Lundmo PI; Sandvik M
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):633-4. PubMed ID: 16505878
    [No Abstract]   [Full Text] [Related]  

  • 47. Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?
    Guay AT; Jacobson J; Perez JB; Hodge MB; Velasquez E
    Int J Impot Res; 2003 Jun; 15(3):156-65. PubMed ID: 12904801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormonal therapy of male hypogonadism.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does testosterone have a role in erectile function?
    Mikhail N
    Am J Med; 2006 May; 119(5):373-82. PubMed ID: 16651047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel.
    Ebert T; Jockenhövel F; Morales A; Shabsigh R
    Eur Urol; 2005 Feb; 47(2):137-46. PubMed ID: 15661407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Serum and salivary testosterone levels in erectile dysfunction].
    Corradi G; Szathmári M
    Orv Hetil; 1998 Aug; 139(34):2021-4. PubMed ID: 9745307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endocrine causes of impotence (nondiabetes).
    Heaton JP; Morales A
    Urol Clin North Am; 2003 Feb; 30(1):73-81. PubMed ID: 12580559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Commentary on adjunctive use of testosterone gel with sildenafil for erectile dysfunction.
    Morales A
    J Urol; 2008 May; 179(5 Suppl):S103. PubMed ID: 18405738
    [No Abstract]   [Full Text] [Related]  

  • 54. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic uses of androgenic agents.
    Smith GB; Farber M
    Compr Ther; 1984 Apr; 10(4):11-6. PubMed ID: 6373113
    [No Abstract]   [Full Text] [Related]  

  • 56. [Correction of androgen deficiency in elderly patients].
    Morgunov LIu
    Klin Med (Mosk); 2007; 85(9):17-22. PubMed ID: 18038561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences.
    Greco EA; Spera G; Aversa A
    Eur Urol; 2006 Nov; 50(5):940-7. PubMed ID: 16979814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.
    Gerstenbluth RE; Maniam PN; Corty EW; Seftel AD
    J Androl; 2002; 23(6):922-6. PubMed ID: 12399540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
    Raynor MC; Carson CC; Pearson MD; Nix JW
    Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Voice changes after androgen therapy for hypogonadotrophic hypogonadism.
    Akcam T; Bolu E; Merati AL; Durmus C; Gerek M; Ozkaptan Y
    Laryngoscope; 2004 Sep; 114(9):1587-91. PubMed ID: 15475787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.